$CYDY CytoDyn The Next Generation of Monoclonal
Post# of 41429
![Avatar](/images/ProfileImages/961064509_31686_6434414D-A8A2-47D8-86F9-362571D63048.png)
The Next Generation of Monoclonal Antibody Therapy
is committed to enhancing the lives of patients through target specific medicine. Their team is focused on developing Leronlimab, a monoclonal antibody CCR5 receptor antagonist, to be used as a platform drug for a variety of indications.
#CYDY
Annual shareholders meeting update.
https://www.cytodyn.com/newsroom/press-releas...meeting-of
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)